Allianz Asset Management
MDGL icon

Allianz Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Allianz Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$913K Buy
1,700
+300
+21% +$154K ﹤0.01% 1903
2026
Q1 		$733K Sell
1,400
-1,000
-42% -$478K ﹤0.01% 1776
2025
Q4 		$1.4M Sell
2,400
-700
-23% -$358K ﹤0.01% 1631
2025
Q3 		$1.42M Buy
3,100
+1,600
+107% +$597K ﹤0.01% 1624
2025
Q2 		$454K Sell
1,500
-56
-4% -$16.7K ﹤0.01% 1846
2025
Q1 		$515K Buy
1,556
+578
+59% +$190K ﹤0.01% 1868
2024
Q4 		$302K Hold
978
– – ﹤0.01% 2003
2024
Q3 		$208K Sell
978
-524
-35% -$134K ﹤0.01% 2077
2024
Q2 		$421K Hold
1,502
– – ﹤0.01% 1888
2024
Q1 		$401K Buy
+1,502
New +$354K ﹤0.01% 1691
2022
Q1 		– Sell
-6,550
Closed -$555K – 2556
2021
Q4 		$555K Sell
6,550
-8,665
-57% -$712K ﹤0.01% 2155
2021
Q3 		$1.21M Buy
15,215
+6,265
+70% +$541K ﹤0.01% 1842
2021
Q2 		$872K Hold
8,950
– – ﹤0.01% 1796
2021
Q1 		$1.05M Buy
+8,950
New +$1.04M ﹤0.01% 1624

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allianz Asset Management's MDGL Position: Q2 2026 in Review

Allianz Asset Management increased its Madrigal Pharmaceuticals (MDGL) stake by 21% in Q2 2026, buying an estimated $154K and bringing the position to 1,700 shares worth $913K. The position accounts for ﹤0.01% of the portfolio, ranked #1903.

Allianz Asset Management first reported a position in MDGL in Q1 2021 and has held it in 14 quarters since. The position peaked at $1.42M in Q3 2025. 415 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Allianz Asset Management held 1,700 shares of Madrigal Pharmaceuticals worth $913K as of Q2 2026.
  • Allianz Asset Management bought 300 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $154K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1903 holding.
  • Allianz Asset Management first reported a position in Madrigal Pharmaceuticals in Q1 2021 and has held it in 14 quarters since.
  • Allianz Asset Management's Madrigal Pharmaceuticals position peaked at $1.42M in Q3 2025.
  • 415 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.